Is Huachansu Beneficial in Treating Advanced Non-Small-Cell Lung Cancer? Evidence from a Meta-Analysis of Its Efficacy Combined with Chemotherapy
- PMID: 26347788
- PMCID: PMC4548072
- DOI: 10.1155/2015/408145
Is Huachansu Beneficial in Treating Advanced Non-Small-Cell Lung Cancer? Evidence from a Meta-Analysis of Its Efficacy Combined with Chemotherapy
Abstract
Background. Huachansu, the sterilized water extract of Bufo bufo gargarizans toad skin, is used in China to alleviate the side-effects and enhance the therapeutic effect of chemotherapy in advanced non-small-cell lung cancer (NSCLC). We conducted a meta-analysis to assess Huachansu's efficacy. Methods. We extensively searched electronic databases (CENTRAL, EMBASE, MEDLINE, CBM, Cochrane Library, CNKI, CEBM, WFDP, CSCD, CSTD, and IPA) for randomized controlled trials containing Huachansu plus chemotherapy as the test group and chemotherapy as the control group. Seventeen trials were selected based on the selection criteria. The pooled relative ratio (RR) of indicators with 95% confidence interval (95% CI) was calculated for efficacy evaluation. Results. The meta-analysis demonstrated a statistically significant improvement in objective tumor response, one-year survival, Karnofsky performance status, pain relief, and alleviation of severe side-effects (nausea and vomiting, leukocytopenia) in the test group as compared to the control group, but no significant difference in thrombocytopenia. Conclusions. This study demonstrated the efficacy of Huachansu combined with chemotherapy in the treatment of advanced NSCLC. However, limitations exist and high-quality trials are needed for further verification.
Figures









Similar articles
-
Efficacy and safety of Huachansu combined with chemotherapy in advanced gastric cancer: a meta-analysis.Med Hypotheses. 2013 Aug;81(2):243-50. doi: 10.1016/j.mehy.2013.04.038. Epub 2013 May 18. Med Hypotheses. 2013. PMID: 23692970
-
Endostar (rh-endostatin) versus placebo in combination with vinorelbine plus cisplatin chemotherapy regimen in treatment of advanced non-small cell lung cancer: A meta-analysis.Thorac Cancer. 2018 May;9(5):606-612. doi: 10.1111/1759-7714.12626. Epub 2018 Mar 25. Thorac Cancer. 2018. PMID: 29575575 Free PMC article.
-
Kanglaite Injection Combined with Chemotherapy versus Chemotherapy Alone for the Improvement of Clinical Efficacy and Immune Function in Patients with Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.Evid Based Complement Alternat Med. 2020 Jan 27;2020:8586596. doi: 10.1155/2020/8586596. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32047528 Free PMC article. Review.
-
[Systematic review and Meta-analysis of efficacy and safety of Huachansu in treating cancer-related pain].Zhongguo Zhong Yao Za Zhi. 2019 Jun;44(12):2627-2636. doi: 10.19540/j.cnki.cjcmm.20190304.003. Zhongguo Zhong Yao Za Zhi. 2019. PMID: 31359733 Chinese.
-
Endostar combined with chemotherapy versus chemotherapy alone for advanced NSCLCs: a meta-analysis.Asian Pac J Cancer Prev. 2011;12(11):2901-7. Asian Pac J Cancer Prev. 2011. PMID: 22393961
Cited by
-
Cinobufacini Injection Improves the Efficacy of Chemotherapy on Advanced Stage Gastric Cancer: A Systemic Review and Meta-Analysis.Evid Based Complement Alternat Med. 2018 Sep 4;2018:7362340. doi: 10.1155/2018/7362340. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30254688 Free PMC article. Review.
-
New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin.Cancer Cell Int. 2019 Apr 11;19:92. doi: 10.1186/s12935-019-0806-1. eCollection 2019. Cancer Cell Int. 2019. PMID: 31011289 Free PMC article. Review.
-
Receptor-specific crosstalk between prostanoid E receptor 3 and bombesin receptor subtype 3.FASEB J. 2018 Jun;32(6):3184-3192. doi: 10.1096/fj.201700337RR. Epub 2018 Jan 22. FASEB J. 2018. PMID: 29401613 Free PMC article.
-
Network Pharmacology Study on the Pharmacological Mechanism of Cinobufotalin Injection against Lung Cancer.Evid Based Complement Alternat Med. 2020 Feb 17;2020:1246742. doi: 10.1155/2020/1246742. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32148531 Free PMC article.
-
Combinational Antitumor Strategies Based on the Active Ingredients of Toad Skin and Toad Venom.Drug Des Devel Ther. 2024 Aug 9;18:3549-3594. doi: 10.2147/DDDT.S469832. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39139676 Free PMC article. Review.
References
-
- Zhao H., Wu X., Wang H., et al. Qualitative and quantitative analysis of cinobufacini injection using rapid separation liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry and HPLC-photodiode array detection, a feasible strategy for the quality control of Chinese medicine injections. Journal of Separation Science. 2013;36(3):492–502. doi: 10.1002/jssc.201200762. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources